Sugi Predict

Sugi Predict / Compounds / SCHEMBL844516

SCHEMBL844516

SCHEMBL844516

CCOC(=O)c1c(C)cc2nc(COCc3ccccc3)n(-c3ccccc3S(=O)(=O)NC)c(=O)c2c1C

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.75
▸ CNR2 P34972 1/20 0.75
▸ CRBN Q96SW2 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ LMNA P02545 4/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MCOLN3 Q8TDD5 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ CDK5 Q00535 2/20 0.34
▸ CDK5R1 Q15078 2/20 0.34
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844571 0.89 CNR1 (0.79) CNR1CNR2ALDH1A1LMNAMAPK1
SCHEMBL844174 0.88 CNR1 (0.87) CNR1CNR2ALDH1A1LMNAMAPK1
Hydrochloric Acid SCHEMBL844735 0.87 CNR1 (0.86) CNR1CNR2ALDH1A1LMNATHRB
SCHEMBL17692331 0.86 CNR1 (0.90) CNR1CNR2ALDH1A1LMNATHRB
SCHEMBL844485 0.86 CNR1 (0.75) CNR1CNR2ALDH1A1LMNAMAPK1
SCHEMBL844904 0.86 CNR1 (0.72) CNR1CNR2ALDH1A1LMNAMAPK1
Sad448 SCHEMBL844484 0.85 CNR1 (1.00) CNR1CNR2ALDH1A1LMNATHRB
SCHEMBL17694535 0.85 CNR1 (0.79) CNR1CNR2ALDH1A1LMNANPSR1
SCHEMBL844232 0.82 CNR1 (0.69) CNR1CNR2MAPTSMN1; SMN2
SCHEMBL844334 0.81 CNR1 (0.68) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552015-B2 Quinazolinone derivatives and their use as CB agonists NOVARTIS AG (CH) 2013-10-08 — — US disclosed
EP-1472234-B1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS CB AGONISTS NOVARTIS AG (CH) 2012-03-28 — — EP disclosed
EP-2319839-A1 Quinazolinone derivatives and their use as CB agonists Novartis AG (CH) 2011-05-11 — — EP disclosed
US-20070265285-A1 Quinazolinone derivatives and their use as CB agonists NOVARTIS AG (CH) 2007-11-15 — — US disclosed
US-20050085493-A1 Quinazolinone derivatives and their use as cb agonists BRAIN CHRISTOPHER T (GB) 2005-04-21 — — US disclosed
EP-1472234-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS CB AGONISTS Novartis AG (CH) 2004-11-03 — — EP disclosed
WO-2003066603-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS CB AGONISTS NOVARTIS AG (CH) 2003-08-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265285-A1 Quinazolinone derivatives and their use as CB agonists CNR1, ADRB1, ADRA1D CNR1 1/4885CNR2 8/4885CRBN 1934/4885
US-20050085493-A1 Quinazolinone derivatives and their use as cb agonists CNR1, ADRB1, ADRA2B CNR1 1/4885CNR2 8/4885CRBN 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.